Loading clinical trials...
Loading clinical trials...
Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Glaukos Corporation
NCT07135167 · Down Syndrome (DS), Keratoconus, and more
NCT07372911 · Keratoconus
NCT06451718 · Keratoconus
NCT04439552 · Pain, Postoperative, Pain, Chronic, and more
NCT02118922 · Keratoconus, Ectasia, and more
Glaukos Clinical Study Site
Westerville, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions